🗂️
Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
grant
Prospective contributions of the vaginal microbiome and immune milieu to spontaneous Chlamydia trachomatis clearance
Organization UNIVERSITY OF MARYLAND BALTIMORELocation BALTIMORE, UNITED STATESPosted 1 Aug 2024Deadline 24 Sept 2025 ⚠️
NIHUS FederalResearch GrantFY2025AccelerationAgeAnaerobic BacteriaAnti-InflammatoriesAnti-Inflammatory AgentsAnti-inflammatoryAntibiotic AgentsAntibiotic DrugsAntibiotic TherapyAntibiotic TreatmentAntibioticsArchivesBacteriaBacterial VaginitisBacterial VaginosisBioinformaticsBiological Response Modifier TherapyBiological TherapyC trachomatisC. trachomatisCannot achieve a pregnancyCell AdhesionCellular AdhesionChlamydia trachomatisChronicCompensationComplexDataDevelopmentDifficulty conceivingEctopic PregnancyEnvironmentEpidemiologyEventFallopian TubesFosteringFunctional MetagenomicsGeneralized GrowthGenitourinaryGenitourinary systemGrowthGuidelinesHealth Care CostsHealth CostsIFN-GammaIFN-gIFN-γIFNGIFNγImmuneImmune InterferonImmune MarkersImmune responseImmunesImmunityImmunologic MarkersImmunologyIn VitroIndividualIndolesInfectionInfertilityInflammationInterferon GammaInterferon Type IIInterruptionInterventionKnowledgeLactic acidLactobacillusLavageLong-term infectionLongitudinal StudiesMammalian OviductsMediatingMetabolicMetabolic Clearance RateMetagenomicsMiscellaneous AntibioticModelingNational Institutes of HealthNonspecific VaginitisParentsPathologyPelvic Inflammatory DiseasePlayPopulationProductionResolutionRickettsia trachomaeRiskRoleSalpinxSamplingSexually Transmitted DiseasesSexually Transmitted DisorderSexually Transmitted InfectionTestingTissue GrowthTranslatingUnited States National Institutes of HealthUrogenitalUrogenital SystemUterine TubesVaccine DesignVaccinesVaginaVenereal DiseasesVenereal DisordersVenereal InfectionsVisitWomanWorkagedagesanaerobeanalyze microbiomebacterial disease treatmentbacterial infectious disease treatmentbiological therapeuticbiological treatmentbiologically based therapeuticsbiotherapeuticsbiotherapycervicovaginalcervicovaginal microbiomechildbearing agechronic infectionclearance ratecohortdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentalepidemiologicepidemiologicalextrauterine pregnancyfertile agefertility cessationfertility lossgenital tracthost responseimmune system responseimmune-based biomarkersimmunological biomarkersimmunological markersimmunoresponseinfertileinnovateinnovationinnovativeinsightlFN-Gammalavage therapylong-term studylongitudinal outcome studiesmetagenomemicrobial consortiamicrobial floramicrobiomemicrobiome analysismicrobiotamicrofloramultiomicsmultiple omicsmultispecies consortianew approachesnon-specific vaginitisnovelnovel approachesnovel strategiesnovel strategyontogenyoviductpanomicsparentpelvic inflammation diseasepelvic inflammation disorderpelvic inflammatory disorderpelvic inflammatory syndromepersistent infectionpost-doctoral trainingpreventpreventingprospectivereproductivereproductive agereproductive tractreproductive yearsresolutionsresponsescreeningscreeningssexually acquired infectionsexually activesocial roletherapeutic targettoolvaccine developmentvaginal biomevaginal floravaginal lactobacillivaginal microbial communityvaginal microbiomevaginal microbiotavaginal microflora
Applications closed.
Description preview
Chlamydia trachomatis (CT) is the most common bacterial sexually transmitted infection. In the U.S., women
aged 15-24 have the highest CT burden: 782,697 cases in 2019. Up to 80% of urogenital CT infections are
asymptomatic, and untreated persistent infection can cause pelvic inflammatory disease, infertility, and ectopic
pregnancy. Risk of…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click